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anBACKGROUND A high percentage of biventricular pacing is required for optimal outcome in patients treated with
cardiac resynchronization therapy (CRT), but the inﬂuence of ectopic beats on the success of biventricular pacing has not
been well established.
OBJECTIVES This study sought to determine if increased ectopic beats reduce the chance of high biventricular pacing
percentage and are associated with subsequent adverse outcomes.
METHODS From the MADIT-CRT (Multicenter Automatic Deﬁbrillator Implantation Trial With Cardiac Resynchronization
Therapy), 801 patients with an implanted CRT-deﬁbrillator device with data available on biventricular pacing percentage
and pre-implantation 24-h Holter recordings were included. Using logistic regression, we estimated the inﬂuence of
ectopic beats on the percentage of biventricular pacing. Reverse remodeling was measured as reductions in atrial and left
ventricular end-systolic volumes (LVESV) at 1 year. Cox models were used to assess the inﬂuence of ectopic beats on the
outcomes of heart failure (HF) or death, ventricular tachyarrhythmias (VTAs), and death.
RESULTS In the pre-implantation Holter recording, ectopic beats accounted for a mean 3.2  5.5% of all beats. The
probability of subsequent low biventricular pacing percentage (<97%) was increased 3-fold (odds ratio: 3.37; 95%
conﬁdence interval: 1.74 to 6.50; p < 0.001) in patients with 0.1% to 1.5% ectopic beats and 13-fold (odds ratio: 13.42;
95% conﬁdence interval: 7.02 to 25.66; p < 0.001) in patients with >1.5% ectopic beats compared with those
with <0.1% ectopic beats. Patients with $0.1% ectopic beats had signiﬁcantly less reverse remodeling (percent
reduction in LVESV 31 15%) than patients with <0.1% ectopic beats (percent reduction in LVESV 39 14%; p< 0.001).
The risk of HF/death and VTA was increased signiﬁcantly in those with 0.1% to 1.5% ectopic beats (hazard ratio: 3.13 and
1.84, respectively) and for >1.5% ectopic beats (hazard ratio: 2.38 and 2.74, respectively).
CONCLUSIONS Relatively low frequencies of ectopic beats ($0.1%) dramatically increase the probability of low
biventricular pacing (<97%), with reduced CRT efﬁcacy by less reverse remodeling and higher risk of HF/death and
VTA. This supports pre-implantation Holter monitoring of patients selected for CRT for optimal outcome. (MADIT-CRT:
Multicenter Automatic Deﬁbrillator Implantation With Cardiac Resynchronization Therapy; NCT00180271)
(J Am Coll Cardiol 2014;64:971–81) © 2014 by the American College of Cardiology Foundation.m the *Heart Research Follow-up Program, University of Rochester Medical Center, Rochester, New York; yDepartment of
rdiology, Gentofte Hospital, Hellerup, Denmark; zArrhythmia Institute, Valley Health System of New York and New Jersey, New
rk, New York and Ridgewood, New Jersey; xCardiology Division, Department of Medicine and Duke Clinical Research Institute,
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NYHA = New York Heart
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PVC = premature ventricular
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VTA = ventricular
tachyarrhythmia
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972C ardiac resynchronization therapy(CRT) in heart failure (HF) patientswith left ventricular dysfunction
and a wide QRS duration has been shown to
reduce mortality and improve HF symptoms
(1,2). The margin of success associated with
implantation of a CRT device, however,
relies on the capability to effectively deliver
biventricular pacing, and even minor reduc-
tions in biventricular pacing can diminish
the beneﬁcial effects of CRT (3–8).SEE PAGE 982
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received March 14, 2014; revised manuscript received JuneVentricular ectopy (isolated premature ven-
tricular complexes [PVCs] or nonsustained
ventricular tachycardia) may preclude the
delivery of 100% effective biventricular pac-ing and thus compromise symptomatic response and
left ventricular reverse remodeling after implantation
with a CRT device (9). Recently, it was shown that atrial
premature complexes (APCs) may play a signiﬁcant
role in loss of optimal biventricular pacing percentage
in patients who receive CRT (10). It is important to
select the right patients for CRT implantation who will
respond to the therapy and to identify those who may
respond suboptimally, to initiate other treatments or
closer follow-up. A 24-h Holter recording is an inex-
pensive and effective method of acquiring accurate
data on both APCs and PVCs; however, limited data
exist regarding the prognostic signiﬁcance of pre-
implantation Holter-detected atrial and ventricular
premature beats in patients undergoing CRT implan-
tation. Therefore, we sought to determine whether the
frequency of premature atrial and ventricular ectopic
beats inﬂuenced optimal biventricular pacing per-
centage and reﬂected reverse remodeling and clinical
events in those patients who were treated with CRT
with an implantable cardioverter-deﬁbrillator (CRT-D)nre
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lator Implantation Trial With Cardiac Resynchroniza-
tion Therapy).
METHODS
The protocol and primary results of the MADIT-CRT
study were published previously (1,11). During the
period 2004 to 2009, we included 1,820 patients with
left ventricular ejection fraction #30%, QRS duration
$130 ms, and ischemic cardiomyopathy of New York
Heart Association (NYHA) functional class I or II or
nonischemic cardiomyopathy of NYHA functional
class II. Patients were enrolled from 110 centers in
Europe, Canada, and the United States and random-
ized in a 3:2 fashion for CRT-D (n ¼ 1,089) or
implantable cardioverter-deﬁbrillator (ICD) devices
(n ¼ 731). Patients were in sinus rhythm at enrollment
and were excluded if they had experienced atrial
arrhythmia within 1 month before enrollment,
although a prior history of atrial ﬁbrillation was not
an exclusion criterion.
STUDY POPULATION. For this study, we analyzed
patients who were randomized to CRT-D, had a pre-
implantation Holter recording performed, had an
average biventricular pacing percentage reading at
the latest possible follow-up, and had interrogation of
the device (n ¼ 801). For echocardiographic mea-
surements and changes at 1-year follow-up, we eval-
uated the changes in 609 patients who also had
paired baseline and 1-year echocardiograms. Figure 1
shows the exact deﬁnitions and ﬂow diagram of the
study population. The Institutional Review Board
approved the protocol at each participating organi-
zation, and each patient provided written informed
consent before enrollment.
Patients assigned to CRT-D underwent 24-h 12-lead
Holter monitoring before implantation. Mortara H12
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ated to this study. Dr. Mittal is a consultant to Boston
cted grants from the Lundbeck Foundation and Falck
Medtronic, Boston Scientiﬁc, ARCA biopharma, and
, Biotronik, St. Jude Medical, CardioFocus, Premier
, Northwestern University, and VytronUS; as well as
r,Medtronic, and Boston Scientiﬁc. Dr. Al-ahmad has
r. Steinberg has received research grants from Boston
Scientiﬁc, St. Jude Medical, and Cameron Health.
l; and honoraria fromMedtronic and St. JudeMedical.
as received a research grant from Boston Scientiﬁc.
e contents of this paper to disclose.
tin Fuster.
. Valentin Fuster.
14, accepted June 10, 2014.
846 patients with Holter recordings and BIV % pacing data
Quintile 1
160 patients
Pct Ectopy <0.1%
[<85 total 
APC or PVC]
Quintile 2-3
321 patients
Pct Ectopy 0.1%-1.5%
[85-1347 total 
APC or PVC]
Quintile 4-5
320 patients
Pct Ectopy >1.5%
[>1347 total
 APC or PVC]
Ectopy burden in %= (APCs + PVCs)/total beats
22 patients had explanted the CRT-D 23 patients crossed over from CRT→ICD
108 patients with no BIV % pacing
data
15 patients <12h Holter recording 35 patients with missing values
8 patients never received CRT-D
1012 CRT-D assigned patients had a Holter monitoring
Final study population for outcomes:
801 patients with Holter recordings and BIV pacing % data
962 patients with Holter ≥12 h:
670 patients with 24 h
794 patients with ≥23 h
Final study population for
echocardiographic changes at 1-year:
609 patients with baseline and 1-year
follow-up echocardiogram
192 patients did not
have follow-up echo
FIGURE 1 Study Population Flow Chart
This ﬂow chart shows the study population of the group with cardiac resynchronization
therapy with implantable cardioverter-deﬁbrillator (CRT-D) from the MADIT-CRT
study and the distribution of patients in 3 groups by ectopic burden as measured by
pre-implantation Holter monitoring. APC ¼ atrial premature complex; BIV ¼ biventricular;
ICD ¼ implantable cardioverter-deﬁbrillator; Pct ¼ percent; PVC ¼ premature ventricular
complex.
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973electrocardiography core laboratory using a Mortara
H-Scribe scanning system (Mortara Instruments,
Milwaukee, Wisconsin). The automatically derived
annotation of beats was veriﬁed for quality by tech-
nicians who were blinded to the data, and data were
used to quantify monitoring period, total beats during
monitoring period, total APCs, and total PVCs. A run
of either APCs or PVCs was deﬁned as 3 consecutive
beats or more. The number of APCs and PVCs com-
bined were then divided by the total number of beats
for a measure of ectopic burden in percentage of
ectopic beats of all beats. The ectopic burden was
then deﬁned by the distribution in percentiles in 3
predeﬁned major groups. The ﬁrst group (low/very
low ectopic burden) was deﬁned as the lowest quin-
tile (0 to 20th percentiles), the second group (mod-
erate ectopic burden) was deﬁned as the 2 middle
quintiles (21st to 60th percentiles), and the third
group (high ectopic burden) was deﬁned as the 2
upper quintiles (61st to 100th percentiles). These
groups translated into <0.1% ectopic beats, 0.1% to
1.5% ectopic beats, and >1.5% ectopic beats, respec-
tively (Figure 1). For supplementary and sensitivity
analysis, we further performed all analyses on the
basis of the distribution by quartiles and quintiles.
DEVICE PROGRAMMING AND INTERROGATION.
Commercially available devices from Boston Scienti-
ﬁc were used in this trial, the programming for which
has been described in the pre-speciﬁed protocol (11).
All devices were interrogated 1 month after enroll-
ment and every 3 months thereafter. All interrogation
discs were sent to an independent core laboratory for
ﬁnal adjudication and interpretation. The biven-
tricular pacing percentage was determined as the
average delivery of biventricular pacing percentage
throughout the follow-up time at the last available
device interrogation. Two groups were selected as
representing high ($97%) and low (<97%) biven-
tricular pacing, on the basis of a recent literature
review and results from the MADIT-CRT trial evalu-
ating the cutoff point of biventricular pacing efﬁcacy
on HF/death and death (5,8,12).
ECHOCARDIOGRAPHY. Echocardiography was per-
formed before implantation and at 1-year follow-up
according to the study protocol. All echocardiograms
were evaluated and measured by the core echocardi-
ography laboratory by use of standardized methods as
deﬁned in the protocol. Different levels of percentage
left atrial volume (LAV), left ventricular end-systolic
volume (LVESV), and left ventricular end-diastolic
volume reduction from baseline to 1-year follow-up
were used to evaluate reverse remodeling of CRT
patients according to the percentage of ectopic beats.A reverse remodeling echocardiographic super-
response was deﬁned as the proportion with changes
with >30% reduction in LVESV.
ENDPOINTS. The primary endpoint of the present
study was deﬁned as death of any cause or nonfatal
HF events, whichever came ﬁrst. The diagnosis
of HF required symptoms consistent with congestive
HF, response to intravenous decongestive therapy for
outpatients, and either oral or intravenous deconges-
tive therapy for patients in the hospital. A mortality
committee unaware of study group assignments
independently adjudicated the diagnosis (11). The
secondary endpoint was malignant ventricular tachy-
arrhythmias (VTAs), deﬁned as appropriate ICD
therapy for ventricular tachycardia or ventricular
ﬁbrillation, delivered as either antitachycardia pacing
or shock. VTAs were adjudicated blindly as described
previously (13). The tertiary endpoint was all-cause
mortality.
STATISTICAL ANALYSIS. For comparison of baseline
variables among the 3 groups, we used chi-square
test or Fisher exact test for categorical variables and
TABLE 1 Baseline Clinical Parameters
Percent Ectopy
<0.1%
Percent Ectopy
0.1% to 1.5% p Value*
Percent Ectopy
>1.5% p Value†
Overall p Value for
Comparisons
Patients 160 (20) 321 (40) 320 (40) <0.001
Female 69 (43) 83 (26) <0.001 46 (14) <0.001 <0.001
Age at enrollment, yrs 59.5  11.2 64.9  10.0 <0.001 66.8  9.8 0.022 <0.001
Cardiac history
Ischemic NYHA functional class I 12 (8) 42 (13) 0.068 49 (15) 0.419 0.054
Ischemic NYHA functional class II 48 (30) 140 (44) 0.004 147 (46) 0.554 0.003
Nonischemic NYHA functional class II 100 (63) 139 (43) <0.001 147 (46) 0.241 0.054
Diabetes 50 (31) 89 (28) 0.422 109 (34) 0.083 0.221
Hypertension 86 (54) 211 (66) 0.008 209 (65) 0.825 0.019
Prior CABG revascularization 21 (13) 90 (28) <0.001 111 (35) 0.070 <0.001
Prior myocardial infarction 43 (27) 148 (47) <0.001 149 (48) 0.876 <0.001
Prior atrial arrhythmias 11 (7) 40 (13) 0.063 37 (12) 0.795 0.167
Prior ventricular arrhythmias 6 (4) 24 (8) 0.111 29 (9) 0.444 0.103
Medications
Antiarrhythmic agent, including
amiodarone and sotalol
8 (5) 34 (11) 0.041 25 (8) 0.224 0.102
ACE inhibitor or ARB 156 (98) 310 (97) 0.782 303 (95) 0.243 0.266
Aldosterone antagonist 50 (31) 109 (34) 0.552 96 (30) 0.283 0.552
Beta-blockers 154 (96) 300 (93) 0.210 291 (91) 0.234 0.091
Statins 98 (61) 221 (69) 0.097 234 (73) 0.233 0.030
Clinical characteristics at enrollment
QRS duration, ms 162.0  17.4 159.3  19.5 0.074 155.7  19.8 0.010 <0.001
LBBB 136 (85) 242 (75) 0.015 198 (62) <0.001 <0.001
RBBB 8 (5) 33 (10) 0.051 56 (18) 0.008 <0.001
Heart rate, beats/min 68.7  10.5 67.5  10.7 0.133 67.0  10.5 0.539 0.140
Creatinine, mg/dl 1.09  0.33 1.14  0.32 0.050 1.19  0.31 0.014 <0.001
Echocardiographic characteristics at enrollment
LVEF, % 29.4  3.5 29.0  3.5 0.135 29.0  3.1 0.972 0.256
LVEDV indexed by BSA 119.1  24.4 124.1  26.6 0.030 123.3  26.6 0.601 0.076
LVESV indexed by BSA 84.4  19.7 88.6  21.7 0.023 87.8  21.3 0.587 0.058
LAV indexed by BSA 43.6  8.9 46.9  9.9 <0.001 46.7  9.8 0.711 <0.001
Holter monitoring and BIV pace interrogation
BIV pacing $97% 148 (93) 250 (78) <0.001 147 (46) <0.001 <0.001
APC total 6 (2–16) 27 (8–77) <0.001 95 (20–787) <0.001 <0.001
PVC total 16 (6–31) 255 (120–572) <0.001 3,593 (2,436–9,242) <0.001 <0.001
Runs of PVCs $1 18 (11) 134 (42) <0.001 243 (76) <0.001 <0.001
Runs of PVCs $10 0 (0) 5 (2) 0.175 85 (27) <0.001 <0.001
Values are n (%), mean  SD, or median (interquartile range). *p value compares percent ectopy <0.1% with percent ectopy 0.1% to 1.5%. †p value compares percent ectopy
0.1% to 1.5% with percent ectopy >1.5%.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker; APC ¼ atrial premature complex; BIV ¼ biventricular; BSA¼ body surface area; CABG¼ coronary
artery bypass graft; LAV ¼ left atrial volume; LBBB ¼ left bundle branch block; LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼ left ventricular ejection fraction;
LVESV ¼ left ventricular end-systolic volume; NYHA ¼ New York Heart Association; PVC ¼ premature ventricular complex; RBBB ¼ right bundle branch block.
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974the Kruskal-Wallis test for continuous variables.
Variables distributed in a non-Gaussian way were
reported with median values (interquartile ranges),
whereas those with a Gaussian distribution were
reported as mean  SD.
Several models were used for analyses in this
study. We used logistic regression models to estimate
the likelihood of receiving a low biventricular pacing
percentage (deﬁned as <97%) versus a high biven-
tricular pacing percentage (deﬁned as $97%). We
used a stepwise selection of variables that had a sig-
niﬁcant (p < 0.05) association with low biventricularpacing and adjusted for these variables along with
those a priori thought to be associated with unfa-
vorable and low biventricular pacing, which were
forced in the model. Separate models evaluated the
inﬂuence of ectopic beats by ectopic burden groups,
as a continuous variable, and by 0.1% increments
using an ordinal scale from 0% to 1.5%, with patients
with >1.5% ectopic beats pooled together.
Echocardiographic measurements and evaluation
from baseline to 1-year follow-up were compared
among the 3 ectopic burden groups with an analysis
of variance if a Gaussian distribution was present
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FIGURE 2 Distribution of Patients According to Percentage
of All Beats That Were Ectopic, Stratiﬁed by High and Low
BIV Pacing Percentage ($97% and <97%)
The proportion of patients with low biventricular (BIV) pacing
percentage (<97%) increased with increasing ectopic burden. In
patients with very low ectopic burden, the majority of patients
achieved a biventricular pacing percentage $97%.
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975for the continuous covariates, or the Kruskal-Wallis
test was used, whereas a chi-square test was used
for the categorical covariates. We used 2 Cox pro-
portional hazard regression models to evaluate the
inﬂuence of percentage of ectopic burden on the
endpoint of HF or death, VTA, and all-cause mor-
tality. These models were adjusted for covariates
found by stepwise selection from the pool of avail-
able covariates and included if signiﬁcant (p < 0.05)
or if thought to be relevant to the outcome a priori
and then forced into the model. The covariates used
in the models are listed below the Tables. Again,
we used the lowest quintile of ectopy as the refer-
ence group. For the all-cause mortality model, we
selected 6 covariates for adjustment despite only 33
deaths, which potentially resulted in a slightly
overﬁtted model.
Odds ratios (ORs) and hazard ratios with their 95%
conﬁdence intervals (CIs) and 2-sided p values are
reported. The cumulative probability of HF or death
was displayed by the method of Kaplan-Meier using
the log-rank test to compare cumulative events. A
2-tailed p value <0.05 was considered statistically
signiﬁcant. Analyses were performed with the SAS
version 9.3 (SAS Institute, Cary, North Carolina).
RESULTS
A total of 801 patients were monitored by pre-
implantation Holter and received CRT-D. Mean
Holter recording time was 23.2  1.7 h. The amounts of
APCs (mean 516 2,100 beats) and PVCs (mean 2,487
4,725 beats) were distributed in a skewed fashion, with
most patients having low numbers of APCs (median 28
[8 to 11]) and PVCs (median 490 [77 to 2,509]). The
mean number of beats measured during Holter moni-
toring was normally distributed in the population
(94,209  14,579 beats). Ectopic beats accounted for a
mean of 3.2  0.8% of all beats, mostly dominated by
PVCs (Table 1). Seventy-six patients (9.5%) had 10% or
more ectopic beats. Nearly one-half of the patients
(49%) experienced at least 1 run of PVCs, and 11% had
>10 runs. Aminor proportion (15%) had at least 1 run of
APCs, and 4% had >10 runs of APCs. Four patients had
runs of APCs of >30 consecutive beats, none of these
had evidence of paroxysmal atrial ﬁbrillation, and
were regular runs of supraventricular tachycardia
during the Holter recording. We created 3 ectopic
burden groups:<0.1%, 0.1% to 1.5%, and>1.5% ectopic
beats (as a percentage of all beats).
Table 1 shows the comparison of baseline charac-
teristics of the 3 groups. In general, those patients
who had higher percentages of ectopic beats had
more advanced cardiac disease than those with <0.1%ectopic beats, as represented by higher proportions
of ischemic cardiomyopathy, hypertension, and prior
coronary artery bypass grafting, whereas there was no
signiﬁcant difference in reported past atrial or ven-
tricular arrhythmias. At baseline, the patients received
the same proportions of medications, except for a
greater use of statins in the 2 upper ectopic groups.
These patients more frequently had non–left bundle
branch block (LBBB) QRS conﬁguration, shorter QRS
durations, and slightly larger ventricular and atrial
volumes.
The likelihood of receiving low biventricular pac-
ing (deﬁned as <97%) was raised with increasing
burden of ectopic beats at baseline (Figures 2 and 3).
The probability of low biventricular pacing was
increased by 18% per percent increase in ectopic beats
(OR: 1.18; 95% CI: 1.14 to 1.23; p < 0.001). There was a
stepwise signiﬁcantly higher probability of low pac-
ing with increasing percentage of ectopic beats, as
illustrated in Figure 3. Table 2 shows that the likeli-
hood of low biventricular pacing in those with ectopic
beats >1.5% was 13-fold higher than in those
with <0.1% ectopic beats (OR: 13.42; 95% CI: 7.02 to
25.66; p < 0.001). The addition of ectopic burden to
the multivariate model increased the C statistic from
0.64 to 0.78. Likewise, the probability of low pacing
was almost 7-fold higher in those with $0.1% ectopic
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FIGURE 3 Likelihood of Attaining Low BIV Pacing Percentage (<97%) by
Increasing Ectopic Burden
Odds ratios of receiving low biventricular (BIV) pacing percentage (<97%) compared with
higher ($97%) in a multivariate logistic regression model. Model adjusted for age, left
bundle branch block, prior ventricular arrhythmias, prior myocardial infarction, and
creatinine levels. Increasing ectopic burden resulted in higher likelihood of low BIV
pacing percentage. CI ¼ conﬁdence interval.
TABLE 2 Association
Likelihood of Low BIV
Per percent increase in
Per 0.1% increase in ec
<0.1% ectopic beats (<
0.1%–1.5% ectopic beats
>1.5% ectopic beats (>
Separate analysis of AP
Per percent increase
Per percent increase
Multivariate logistic regre
ventricular arrhythmias, pr
in the range from 0% to 1
1.16; 95% CI: 1.13 to 1.19;
CI ¼ conﬁdence interval
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976beats than in those with <0.1% ectopic beats (OR:
6.79; CI: 3.64 to 12.68; p < 0.001).
When we evaluated APCs and PVCs separately, it
was evident that the ectopic burden of APCs alone
independently increased the likelihood of low pacingBetween Number of Ectopic Beats (Ectopic Burden) and
Pacing (<97%) Versus High Percentage ($97%)
Odds Ratio:
BIV Pacing <97% vs.
BIV Pacing $97% 95% CI p Value
ectopic beats 1.18 1.14–1.23 <0.001
topic beats* 1.02 1.01–1.02 <0.001
85 total APCs or PVCs) 1.00 ¼ ref NA NA
(85–1,347 total APCs or PVCs) 3.37 1.74–6.50 <0.001
1,347 total APCs or PVCs) 13.42 7.02–25.66 <0.001
Cs and PVCs
in APCs/total beats 1.09 1.02–1.16 0.015
in PVCs/total beats 1.22 1.16–1.28 <0.001
ssion model. Adjusted for age, left bundle branch block QRS conﬁguration, prior
ior myocardial infarction, and creatinine level. *If estimated by use of an ordinal scale
.5% by 0.1% increase and pooling patients with more than 1.5% ectopy: odds ratio:
p < 0.001 per 0.1% increase in ectopic beats.
; NA ¼ not applicable; ref ¼ reference; other abbreviations as in Table 1.by 9% per percent increase in APC burden (OR: 1.09;
95% CI: 1.02 to 1.16; p ¼ 0.015), whereas an increase in
PVC burden increased the likelihood by 22% per
percent increase in PVC burden (OR: 1.22; 95% CI: 1.16
to 1.28; p < 0.001). Because of the left skew in ectopic
distribution, we additionally used an ordinal scale by
0.1% in the range 0% to 1.5% and showed that few
subtle changes in ectopic burden increased the like-
lihood of low biventricular pacing by 16% per 0.1%
increase in ectopic beats (OR: 1.16; 95% CI: 1.13 to 1.19;
p < 0.001).
A total of 609 patients underwent the 1-year
follow-up echocardiogram and thus had paired
1-year analyses with baseline measurements. The
echocardiographic measured reductions in LVESV
and left ventricular end-diastolic volume were
signiﬁcantly greater in patients who had a low
amount of ectopic beats. Patients with $0.1% ectopic
beats had signiﬁcantly less reverse remodeling
(reduction in LVESV 31  15%) than patients
with <0.1% ectopic beats (reduction in LVESV 39 
14%; p < 0.001). The same was evident for changes in
LAV and left ventricular ejection fraction. (Figure 4
shows all 3 ectopic groups.) In addition, patients
with a low (<0.1%) percentage of ectopic beats were
signiﬁcantly more likely to be super-responders
(deﬁned as >30% reduction in LVESV), with 78% of
the patients experiencing super-response in LVESV.
Patients with 0.1% to 1.5% ectopic beats were super-
responders in 57% of the cases, whereas those
with >1.5% ectopic beats had a super-response in 50%
of the cases.
Long-term outcomes by ectopic burden are shown
by Kaplan-Meier graph (Figure 5A) and the multivar-
iate Cox regression model in Table 3. Patients with a
low or very low (<0.1%) frequency of ectopic beats
had a signiﬁcantly more favorable outcome, with a
cumulative probability of HF hospitalization or death
as low as 5% at 4-year follow-up. Patients with 0.1%
to 1.5% ectopic beats had an unfavorable outcome
compared with those in the lowest group, with a
signiﬁcant 3-fold relative increase in risk of HF hos-
pitalization or death (hazard ratio: 3.13; CI: 1.40 to
7.02; p ¼ 0.005). There was a negligible increase in
risk of HF or death evident among the patients who
had the highest amount of ectopic beats (>1.5%)
compared with the middle ectopic beat group
(Table 3, Figures 5A and 5C). The linear relation in risk
of HF or death up to a cutoff of 1.5% ectopic beats was
evident, with an 8% increase in HF or death for each
0.1% increase in ectopic beats. As also shown in
Table 3, the increased risk of HF/death was driven by
HF hospitalizations and primarily by the ectopic
burden of PVCs. There was no signiﬁcant increase in
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FIGURE 4 Echocardiography-Measured Changes at 1-Year Follow-Up by
Ectopic Burden During Pre-Implantation 24-h Holter Monitoring in
Cardiac Resynchronization Therapy Patients
Increasing baseline ectopic burden resulted in less reverse remodeling as measured by
1-year changes in left ventricular end-systolic volume (LVESV), left ventricular end-diastolic
volume (LVEDV), left atrial volume (LAV), and left ventricular ejection fraction (LVEF).
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977HF/death by burden of APCs alone, despite the
separate inﬂuence of APCs on biventricular pacing
percentage. Also, there was no signiﬁcant association
between ectopic burden and all-cause mortality.
We further assessed the risk of VTAs, which were
signiﬁcantly associated with an increasing percentage
of ectopic beats. The cumulative 4-year event rates
were 10%, 20%, and 31% in the 3 groups, respectively,
as shown in Figure 5B, which was conﬁrmed in
multivariate analysis shown in Table 3. The risk of
VTAs by increasing ectopic burden was driven by the
inﬂuence of PVCs. APCs were not independently
associated with increased risk of VTAs.
DISCUSSION
In this analysis, we aimed to determine whether a
high burden of ectopic beats attenuated the proba-
bility of high biventricular pacing and whether
ectopic beats affected reverse remodeling and long-
term outcome. The major ﬁndings from this study
are that patients who have a relatively low burden of
ectopic beats, as low as 1 in 1,000 beats as identiﬁed
by pre-implantation 24-h Holter recordings, are more
likely to attain low biventricular pacing, as well as
adverse echocardiographic reverse remodeling pa-
rameters and clinical outcomes (Central Illustration).
Pre-implantation Holter monitoring also identiﬁed a
patient subgroup (<0.1% ectopy) with a very high
likelihood of achieving high biventricular pacing and
with favorable reverse remodeling and clinical out-
comes. The patients who had a low prevalence of
ectopic beats also had other pre-implantation char-
acteristics for favorable response in reverse remod-
eling and clinical outcomes. At baseline, these
patients had many prerequisites already known to
result in superior response: female sex, LBBB QRS
conﬁguration, lower age, and wider QRS conﬁgura-
tions. Likewise, the ventricular and atrial volumes
measured by echocardiography at baseline were
somewhat larger in patients with high percentages of
ectopic beats. Despite this, the relative reductions at
1-year follow-up echocardiographic volumes were
signiﬁcantly smaller in these patients than in the
patients with the lowest percentage of ectopy. Our
study is further conﬁrmatory of the well-known as-
sociation of PVCs and the risk of future sustained
VTAs and progression of HF. However, this study
uniquely assessed the probability of obtaining high
biventricular pacing and the link to changes in echo-
cardiographic parameters.
The frequency of APCs and PVCs varies signiﬁ-
cantly depending on the characteristics of the study
population. In our population, the ectopic burdenwas dominated by PVCs, and 50% of the patients
experienced >490 PVCs, whereas the median num-
ber of APCs was only 28. A total of 40% of the pa-
tients had >1,000 PVCs, which is slightly less than
but comparable to the results of a smaller study
(n ¼ 102 patients in NYHA functional class II and III)
(14), in which 48% of the patients had >1,000 PVCs.
In our study, we found some important differences
in clinical characteristics associated with higher
prevalence of ectopic beats. Frequent PVCs were
much more common among the elderly, in males, in
those with ischemic cardiomyopathy, and in those
with dilated ventricles, which is consistent with
reports on characteristics of nonsustained ventricu-
lar tachycardia from SCD-HeFT (Sudden Cardiac
Death in Heart Failure Trial) (15), CHF-STAT
(Congestive Heart Failure: Survival Trial of Antiar-
rhythmic Therapy) (16), and GESICA-GEMA (Grupo
de Estudio de la Sobrevida en la Insuﬁciencia Car-
diaca en Argentina-Grupo de Estudios Multicéntricos
en Argentina) (17).
PVCs can worsen or cause HF, and this association
has been determined in many studies. PVCs are
associated with a decrease in both diastolic and sys-
tolic function. The causal relationship, whether PVCs
are a result of underlying cardiomyopathy or can
contribute to cardiomyopathy or both, is not well
established. In HF patients, however, PVCs have been
shown to be an independent marker of subsequent
malignant VTAs and sudden cardiac death (18–20). In
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FIGURE 5 Kaplan-Meier Estimates of Primary Endpoint of Hospitalization
for HF or Death and Secondary Endpoint of Hospitalization for VTAs,
and Event Rates of Total HF or Death Events and Total VTAs, by
Ectopic Burden at Pre-Implantation 24-h Holter Monitoring
(A) An increasing ectopic burden (>0.1%) resulted in a signiﬁcantly increased
risk of heart failure (HF)/death compared with <0.1% ectopic beats. No
signiﬁcant difference was found between groups with 0.1% to 1.5% ectopic
beats and those with>1.5% ectopic beats for risk of HF/death. (B) An increase
in the number of ectopic beats was signiﬁcantly associated with increased risk
of ventricular tachyarrhythmia (VTA). (C) An increase in the amount of ectopic
beats resulted in an increased risk of HF/death with no further increase in
event rates for >1.5% ectopic beats compared with 0.1% to 1.5% ectopic
beats. VF ¼ ventricular ﬁbrillation; VT ¼ ventricular tachycardia.
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978this study of mild HF patients, we found PVCs and
ectopic beats were not only independent markers of
future hospitalizations for HF or death and VTAs
but also signiﬁcantly associated with less reverse re-
modeling, a lower probability of super CRT response,
and a higher probability of low biventricular pacing.
Causality is difﬁcult to establish in this type of retro-
spective study, but there appears to be a direct link
between an inability to obtain a high biventricular
pacing percentage because of high burden of ectopic
beats and the subsequent adverse outcome.
The mechanism by which PVCs and APCs atten-
uate biventricular pacing and worsen outcome is
complex and multifactorial. PVCs have a deleterious
effect on the clinical course of patients with HF in
general, because they impair cardiac output and
may reﬂect electrical instability in the myocardium
or a myocardial arrhythmogenic “substrate” and
thus may be a marker of impending malignant VTAs
(18–20). These effects in combination with increased
sympathetic activity and possible proarrhythmic
medications all contribute to adverse outcomes.
However, PVCs also interfere with effective biven-
tricular pacing through several other mechanisms;
a PVC that inhibits a paced beat may result in
resetting of the post-ventricular atrial refractory
period, such that the next sinus atrial electrogram is
ignored and not sensed. Further loss of ventricular
capture and inappropriate long atrioventricular-
delay programming are factors that inhibit biven-
tricular pacing in the presence of PVCs. Further
PVCs increase intraventricular dyssynchrony, which
interferes with delivery of effective biventricular
pacing and promotes deterioration of left ventricu-
lar function.
APCs, although not as frequent a contributor as
PVCs to reduced biventricular pacing, may inhibit
optimal biventricular pacing through various degrees
of fused beats by intrinsic conduction and may be a
marker of later runs of clinically unrecognized atrial
ﬁbrillation, as has been shown in the general popu-
lation (21). For atrial ﬁbrillation, this may lead to
irregular ventricular responses (R-R irregularity). An
irregular ventricular response results in increased
sympathetic nerve activity, which may promote VTAs
and worsen the clinical course. Atrial-ventricular
irregularity and loss of coordination also cause
worsening of mitral regurgitation and a loss of the
atrial contribution to cardiac output and exacerbate
heart failure symptoms (22). Permanent atrial ﬁbril-
lation has been associated with lower rates of high
biventricular pacing and adverse outcomes (5,23,24).
We found that an increasing burden of APCs
increased the likelihood of low biventricular pacing
TABLE 3 Multivariate Cox Regression Analysis of Endpoint of Hospitalization for HF or Death, VTAs, and Death Alone
n
HF/Death VTAs Death Only
Events
Hazard
Ratio* 95% CI p Value Events
Hazard
Ratio† 95% CI p Value Events
Hazard
Ratio‡ 95% CI p Value
Per 0.1% increase in ectopic beats§ NA NA 1.08 1.01–1.15 0.020 NA 1.05 1.02–1.07 0.039 NA 0.99 0.93–1.05 0.70
<0.1 % ectopic beats 160 8 1.00 ¼ ref NA NA 15 1.00 ¼ ref NA NA 4 1.00 ¼ ref NA NA
<85 total APCs or PVCs
0.1%–1.5% ectopic beats 321 51 3.13 1.40–7.02 0.005 60 1.84 1.04–3.28 0.037 13 1.00 0.32–3.15 0.99
85–1,347 total APCs or PVCs
>1.5% ectopic beats 320 49 2.38 1.04–5.42 0.039 89 2.74 1.56–4.82 0.001 16 0.82 0.25–2.65 0.74
>1,347 total APCs or PVCs
Separate analysis of APCs and PVCs
Per 0.1% increase in APCs§ NA NA 1.01 0.84–1.21 0.96 NA 1.01 0.98–1.05 0.46 NA 0.98 0.91–1.07 0.69
Per 0.1% increase in PVCs§ NA NA 1.08 1.02–1.15 0.016 NA 1.05 1.02–1.07 <0.001 NA 1.00 0.95–1.06 0.94
*Adjusted for female sex, ischemic cardiomyopathy, left bundle branch block (LBBB), worst New York Heart Association (NYHA) functional class ¼ III, left ventricular ejection fraction (LVEF), and creatinine
level. †Adjusted for female sex, ischemic cardiomyopathy, LBBB, prior ventricular arrhythmias, LVEF, and non-U.S. enrolling centers. ‡Adjusted for female sex, ischemic cardiomyopathy, LBBB, worst NYHA
class III, LVEF, and creatinine level. §Estimated by use of an ordinal scale in the range from 0% to 1.5% by 0.1% increase, and pooling patients with more than 1.5% ectopy as a linear relation was no more
evident for heart failure/death above this cutoff for ectopic beats.
VTA ¼ ventricular tachyarrhythmias; other abbreviations as in Table 2.
CENTRAL ILLUSTRATION High Frequency of Atrial and Ventricular Ectopic Beats
High frequency of atrial and ventricular ectopic beats measured by 24-h Holter recording
is associated with reduced biventricular (BIV) pacing percentage and adverse outcomes.
CRT ¼ cardiac resynchronization therapy.
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979by 9% per percent increase in APC ectopic burden,
which supports an important role of APCs as a factor
to be considered when one evaluates the biven-
tricular response. On the other hand, we did not ﬁnd
any evidence that APCs were independently associ-
ated with adverse outcome. That a decreased proba-
bility of high biventricular pacing by an increasing
amount of APCs translates into HF events is therefore
speculative.
The cumulative incidence of HF/death (8 events in
160 patients) in the group with low ectopic burden
was found to be even lower than a previously devel-
oped risk score that selected the highest quartile of
CRT responders and estimated outcome (3-year
rate of 11%), as previously done in the MADIT-CRT
population (25), which indicates that a very low
ectopic burden is a robust marker of very low risk in
HF patients. The 4-year cumulative incidence of HF/
death with >1.5% ectopic beats reached similar rates
as in the original ICD-only cohort from the MADIT-
CRT population (4-year rate of 35%) (1). The rather
low cumulative incidence of VTAs in this group not
only denotes the association between ectopic burden
and risk of VTA but also implies a reduction in VTAs
by higher rates of biventricular pacing percentage,
which remains to be explored in detail.
Using quantiﬁcation of ectopic beats before im-
plantation, we were able to identify a large group of
HF patients with a very low event rate of hospitali-
zation for HF/death, as well as malignant ventricular
tachyarrhythmias. Furthermore, these patients
experienced a high probability of achieving a high
biventricular pacing percentage. We were able to
distinguish and specify that even rather infrequentectopic beats in the range of 0.1% to 1.5% were
signiﬁcantly associated with clinical deterioration
and reduced response in reverse remodeling, as well
as a lower probability of high biventricular pacing
percentage. This suggests the use of pre-implantation
Holter monitoring for selection of patients for opti-
mization of CRT and risk stratiﬁcation of HF patients
and supports aggressive treatment of PVCs to
enhance biventricular optimization.
STUDY LIMITATIONS. We had no information on
physician-initiated therapies or the indications for
therapy for high burdens of ectopic beats. In some
cases, patients may have been treated more aggres-
sively with antiarrhythmic medications, ablation
procedures, changes in atrioventricular delay, or
other CRT programming optimizations, or in other
ways may have been handled differently from those
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The
presence of a high percentage of biventricular paced
beats reduces the risks of death or hospitalization for
heart failure in patients with reduced left ventricular
ejection fraction and wide QRS complexes.
COMPETENCY IN PATIENT CARE: Patients
with $0.1% ectopic beats often have <97%
biventricular paced beats and are at higher risk
of developing decompensated heart failure,
ventricular arrhythmias, or death.
TRANSLATIONAL OUTLOOK: Among patients
with implanted cardiac resynchronization devices,
evaluation of the frequency of ectopic beats by 24-h
Holter monitoring can identify those likely to have a
high percentage of biventricular pacing who will have
improved clinical outcomes. Prospective studies will
be necessary to evaluate whether patients identiﬁed
by this method will beneﬁt from more aggressive
antiarrhythmic therapy.
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980with low burdens of ectopic beats to accommodate
the high burden of PVCs. Furthermore, this is a post-
hoc analysis, and although the statistical models take
many confounders into account in the multivariate
models, there may be unmeasured confounding in-
ﬂuence on the results. In particular, patients with low
amounts of ectopy generally were less sick and had
many of the characteristics known to be associated
with CRT response, such as LBBB QRS morphology,
nonischemic cardiomyopathy, and female sex. In the
multivariate analysis for the endpoints of HF/death,
VTA, and death, we adjusted for factors that were
signiﬁcantly associated with the outcome, but other
unknown imbalances between the ectopic groups
may have affected the results.
CONCLUSIONS
Pre-implantation 24-h Holter monitoring can identify
CRT patients with a higher probability of low biven-
tricular pacing. An increasing number of ectopic beats
is associated with low biventricular pacing, less
reverse remodeling, and adverse clinical outcome.
Similarly, it identiﬁes patients with a very low num-
ber of ectopic beats, <1 in 1,000, who are very likely
to obtain high biventricular pacing and who have a
very low risk of adverse outcomes. Holter monitoring
can help identify patients unlikely to respond to CRT,
and this study suggests that patients with frequent
APCs or PVCs should be followed up closely so that
measures can be taken to optimize biventricular
pacing.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Martin H. Ruwald, Heart Research Follow-up Pro-
gram, University of Rochester Medical Center, 265
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